Mesenchymal Stem Cell Exosomes as Immunomodulatory Therapy for Corneal Scarring
Corneal scarring is a leading cause of worldwide blindness. Human mesenchymal stem cells (MSC) have been reported to promote corneal wound healing through secreted exosomes. This study investigated the wound healing and immunomodulatory effects of MSC-derived exosomes (MSC-exo) in corneal injury thr...
Main Authors: | Hon Shing Ong, Andri K. Riau, Gary Hin-Fai Yam, Nur Zahirah Binte M. Yusoff, Evelina J. Y. Han, Tze-Wei Goh, Ruenn Chai Lai, Sai Kiang Lim, Jodhbir S. Mehta |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/8/7456 |
Similar Items
-
Mesenchymal stem cell exosomes as immunomodulatory therapy for corneal scarring
by: Ong, Hon Shing, et al.
Published: (2023) -
Regenerative Therapy for Corneal Scarring Disorders
by: Christine Chandran, et al.
Published: (2024-03-01) -
Combined Therapy Using Human Corneal Stromal Stem Cells and Quiescent Keratocytes to Prevent Corneal Scarring after Injury
by: Vishal Jhanji, et al.
Published: (2022-06-01) -
Control of Scar Tissue Formation in the Cornea: Strategies in Clinical and Corneal Tissue Engineering
by: Samantha L. Wilson, et al.
Published: (2012-09-01) -
Good manufacturing practice production of human corneal limbus-derived stromal stem cells and in vitro quality screening for therapeutic inhibition of corneal scarring
by: Mithun Santra, et al.
Published: (2024-01-01)